Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality

Cancer Research

Volumn 58, Issue 5, 1998, Pages 933-939

  Farrell, Catherine L ^a   Bready, James V ^a   Rex, Karen L ^a   Chen, Jennifer N ^a   DiPalma, Christopher R ^a   Whitcomb, K Lane ^a   Yin, Songmei ^a   Hill, David C ^a   Wiemann, Bernadette ^a   Starnes, Charlie O ^a   Havill, Andrew M ^a   Lu, Zhao N ^a   Aukerman, Sharon L ^a,c   Pierce, Glenn F ^a,c   Thomason, Arlen ^a   Potten, Christopher S ^b   Ulich, Thomas R ^a   Lacey, David L ^a  

^a AMGEN INC   (United States)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c Prizm Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; FLUOROURACIL; KERATINOCYTE GROWTH FACTOR; METHOTREXATE; RECOMBINANT KERATINOCYTE GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; FEMALE; INTESTINE CRYPT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORTALITY; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; WEIGHT GAIN; WHOLE BODY RADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HUMANS; INTESTINAL DISEASES; INTESTINAL MUCOSA; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; RADIATION INJURIES, EXPERIMENTAL; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS;

EID: 0032030965     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rubin, J. S., Osada, H., Finch, P. W., Taylor, W. G., Rudikoff, S., and Aaronson, S. A. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc. Natl. Acad. Sci. USA, 86: 802-806, 1989.
2. Finch, P. W., Rubin, J. S., Miki, T., Ron, D., and Aaronson, S. A. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science (Washington DC), 245: 752-755, 1989.
3. Pierce, G. F., Yanagihara, D., Klopchin, K., Danilenko, D. M., Hsu, E., Kenny, W. C., and Morris, C. F. Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J. Exp. Med., 179: 831-840, 1994.
4. Ulich, T. R., Yi, E. S., Cardiff, R., Yin, S., Bikhazi, N., Blitz, R., Morris, C. F., and Pierce, G. F. Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. Am. J. Pathol., 144: 862-868, 1994.
5. Ulich, T. R., Yi, E. S., Longmuir, K., Yin, S., Blitz, R., Morris, C. F., Housley, R. M., and Pierce, G. F. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J. Clin. Invest., 93: 1298-1306, 1994.
6. Yi, E. S., Yin, S., Harclerode, D. L., Bedoya. A., Bikhazi, N., Housley, R. M., Aukerman, S. L., Morris, C. F., Pierce, G. F., and Ulich, T. R. Keratinocyte growth factor induces pancreatic ductal epithelial proliferation. Am. J. Pathol., 145: 80-85, 1994.
7. Yi, E. S., Shabaik, A. S., Lacey, D. L., Bedoya, A. A., Yin, S., Housley, R. M., Danilenko, D. M., Benson, W., Cohen, A. M., Pierce, G. F., Thomason, A., and Ulich, T. R. Keratinocyte growth factor causes proliferation of urothelium in vivo. J. Urol., 154: 1566-1570, 1995.
8. Danilenko, D. M., Ring, B. D., Yanagihara, D., Benson, W., Wiemann, B., Starnes, C. O., and Pierce, G. F. Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Am. J. Pathol., 147: 145-154, 1995.
9. Housley, R. M., Morris, C. F., Boyle, W., Ring, B., Biltz, R., Tarpley, J. E., Aukerman, S. L., Devine, P. L., Whitehead, R. H., and Pierce, G. F. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J. Clin. Invest., 94: 1764-1777, 1994.
10. Miki, T., Bottaro, D. P., Fleming, T. P., Smith, C. L., Burgess, W. H., Chan, A. M-L., and Aaronson, S. A. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sci. USA, 89: 246-250, 1992.
11. Cascinu, S. Management of diarrhea induced by tumors or cancer therapy. Curr. Opin. Oncol., 7: 325-329, 1995.
12. Potten, C. S., and Hendry, J. H. The microcolony assay in mouse small intestine. In: C. S. Potten and J. H. Hendry (eds.), Cell Clones: Manual of Mammalian Cell Techniques, pp. 50-60. Edinburgh, Scotland: Churchhill Livingstone, 1985.
13. Potten, C. S., Rezvani, M., Hendry, J. H., Moore, J. V., and Major, D. The correction of intestinal microcolony counts for variation in size. Int. J. Radiat. Biol., 40: 321-326, 1981.
14. Roberts, S. A. DRFIT. A program for fitting radiation survival models. Int. J. Radiat. Biol., 57: 1243-1246, 1990.
15. 50 and cell survival, and their modification by antibodies. Radiat. Res., 96: 100-112, 1983.
16. Klein, R. M. Small intestinal proliferation during development. In: E. Lebenthal (ed.), Human Gastrointestinal Development, pp. 367-392. New York: Raven, 1989.
17. Potten, C. S. Interleukin-11 protects the clonogenic stem cells in murine small-intestinal crypts from impairment of their reproductive capacity by radiation. Int. J. Cancer. 62: 356-361, 1995.
18. Potten, C. S. Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells, 14: 1-8, 1996.
19. Du, X. X., Doerschuk, C. M., Orazi, A., and Williams, D. A. A bone marrow stromal-derived growth factor interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood, 83: 33-37, 1994.
20. Potten, C. S., Booth, D., and Haely, J. D. Pretreatment with transforming growth factor β-3 protects small intestinal stem cells against radiation damage in vivo. Br. J. Cancer, 75: 1454-1459, 1997.
21. Booth, C., and Potten, C. S. Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Proliferation. 28: 581-594, 1995.
22. McCormack, E. S., Borzillo, G. V., Ambrosino, C., Mak, G., Hamablet, L., Qu, G-Y., and Haley, J. D. Transforming growth factor-β3 protection of epithelial cells from cycle-selective chemotherapy in vitro. Biochem. Pharmacol., 53: 1149-1159, 1997.
23. Withers, H. R., and Elkind, M. M. Microcolony survival assay for cells of mouse intestinal mucosa exposed to irradiation. Int. J. Radiat. Biol., 17: 261-267, 1970.
24. Potten, C. S. Regeneration in epithelial proliferative units as exemplified by small intestinal crypts. Ciba Found. Symp., 160: 54-76. 1991.
25. Zeeh, J. M., Procaccino, F., Hoffmann, P., Aukerman, S. L., McRoberts, J. A., Soltani, S., Pierce, G. F., Lakshmanan, J., Lacey, D., and Eysselein, V. E. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology, 110: 1077-1083, 1996.
26. Pierce, G. F., Yanagihara, D., Klopchin, K., Danilenko, D. M., Hsu, E., Kenny, W. C., and Morris, C. F. Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J. Exp. Med., 170: 831-840, 1994.
27. Frank, S., Muna, B., and Werner, S. The human homologue of a bovine-non-selenium glutathione peroxidase is a novel keratinocyte growth factor-regulated gene. Oncogene, 14: 915-921, 1997.
28. Forstner, J. F., and Forstner, G. G. Gastrointestinal mucus. In: L. Johnson (ed.), Physiology of the Gastrointestinal Tract, pp. 1255-1283. New York: Raven, 1994.
29. Poulsom, R., and Wright, N. A. Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. Am. J. Physiol., 265: G205-G213, 1993.
30. Playford, R. J., Marchbank, T., Goodlad, R. A., Chinery, R. A., Poulsom, R., Hanby, A. M., and Wright, N. A. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc. Natl. Acad. Sci. USA, 93: 2137-2142, 1996.
31. Mashimo, H., Wu, D-C., Podolsky, D. K., and Fishman, M. C. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science (Washington DC), 274: 262-265, 1996.
32. Ning, S., Shui, C., Khan, W. B., Benson, W., Lacey, D. L., and Knox, S. J. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo. Int. J. Radiat. Oncol. Biol. Phys., 40: 177-187, 1998.
33. Drugan, C. S., Stone, A., Game, S. M., and Prime, S. S. The mitogenic effect of KGF and the expression of its cell surface receptor on cultured normal and malignant human oral keratinocytes and on contiguous fibroblasls. J. Oral Pathol. Med., 26: 327-333, 1997.
34. Fennelly, D., Raptis, G., Crown, J. P. A., and Norton, L. Clinical potential of hematopoietic growth factor support for high-dose chemotherapy. In: G. Morstyn and W. Sheridan (eds.), Cell Therapy. Stem Cell Transplantation. Gene Therapy, and Cellular Immunotherapy, pp. 299-311. Cambridge, MA: Cambridge University Press. 1996.